have a family history of breast, ovarian, endometrial (uterine), prostate, or colon cancer, have had breast cancer, have a first-degree relative (mother, daughter, sister) who has had ovarian cancer. (The risk is greater if two or more first-degree relatives had the disease. Having a gra...
Publication » Ovarian versus uterine serous carcinomas: Clinicopathologic and miRNA analysis.doi:10.1016/j.ygyno.2013.04.274Ahmad, A.Ahmad, S.Weidhaas, J.Hui, P.Santin, A.Azodi, M.Silasi, D.Schwartz, P.Rutherford, T.Ratner, E.
Ovarian cancer (OC) is the most lethal gynecological malignancy due to tumor heterogeneity, the lack of reliable early diagnosis methods and the high incidence of chemoresistant recurrent disease. Although there are developments in chemotherapies and sur
Ovarian cancer (OC) is the leading cause of death from gynaecologic malignancies, with an observed number of deaths in the EU in 2017 of 26.221 and a prediction of 26.500 deaths in 2022 [1]. The ovarian, fallopian tube, and primary peritoneal cancer are considered a single entity (referred...
Ovarian cancer (OC) is the most lethal gynecological malignancy due to tumor heterogeneity, the lack of reliable early diagnosis methods and the high incidence of chemoresistant recurrent disease. Although there are developments in chemotherapies and sur
BasalFSHlevel is traditionally determined on day 3 of themenstrual cycle, counting from the first day of uterinebleeding. A greater production of FSH in theanterior pituitarygland is symptomatic of inadequate production of inhibitory hormones, particularlyinhibin Band estradiol, by the maturing cohort ...
Bias versus causality: interpreting recent evidence of association between endometriosis and ovarian cancer - ScienceDirect Objective To establish whether causality versus biases may explain the association of endometriosis and ovarian cancer. Design We employ the nine criteria ... Paola,Viganò,and,......
Uterine leiomyosarcoma (LMS) is rare but primary ovarian LMS is even rarer constituting less than 0.1% of all gynecologic disorders. Neither histologic features nor immunohistochemistry could be utilized to distinguish between uterine or ovarian origin.
In this chapter, the embryology and development of the Müllerian tract is first introduced. The chapter is then divided into two major sections: pathology of the uterus and the ovary. In the uterine portion, benign endometrium is first discussed and the
Ovarian cancer is not a single disease and can be subdivided into at least five different histological subtypes that have different identifiable risk factors, cells of origin, molecular compositions, clinical features and treatments. Ovarian cancer is a global problem, is typically diagnosed at a late...